Literature DB >> 17309930

Gender differences in the treatment for acute myocardial infarction: bias or biology?

R David Anderson, Carl J Pepine.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17309930     DOI： 10.1161/CIRCULATIONAHA.106.685859

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  41 in total

1.  Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study.

Authors:  Janet Wei; Puja K Mehta; B Delia Johnson; Bruce Samuels; Saibal Kar; R David Anderson; Babak Azarbal; John Petersen; Barry Sharaf; Eileen Handberg; Chrisandra Shufelt; Kamlesh Kothawade; George Sopko; Amir Lerman; Leslee Shaw; Sheryl F Kelsey; Carl J Pepine; C Noel Bairey Merz
Journal:  JACC Cardiovasc Interv       Date:  2012-06       Impact factor: 11.195

2.  Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies.

Authors:  C Noel Bairey Merz; Saralyn Mark; Barbara D Boyan; Alice K Jacobs; Prediman K Shah; Leslee J Shaw; Doris Taylor; Eduardo Marbán
Journal:  J Womens Health (Larchmt)       Date:  2010-06       Impact factor: 2.681

3.  Myocardial steatosis as a possible mechanistic link between diastolic dysfunction and coronary microvascular dysfunction in women.

Authors:  Janet Wei; Michael D Nelson; Edward W Szczepaniak; Laura Smith; Puja K Mehta; Louise E J Thomson; Daniel S Berman; Debiao Li; C Noel Bairey Merz; Lidia S Szczepaniak
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-30       Impact factor: 4.733

4.  In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Daniel F Pauly; B Delia Johnson; R David Anderson; Eileen M Handberg; Karen M Smith; Rhonda M Cooper-DeHoff; George Sopko; Barry M Sharaf; Sheryl F Kelsey; C Noel Bairey Merz; Carl J Pepine
Journal:  Am Heart J       Date:  2011-09-06       Impact factor: 4.749

Review 5.  Estrogen, hormonal replacement therapy and cardiovascular disease.

Authors:  Xiao-Ping Yang; Jane F Reckelhoff
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-03       Impact factor: 2.894

Review 6.  Gender differences in cardiovascular therapy: focus on antithrombotic therapy and percutaneous coronary intervention.

Authors:  Juan Luis Gutiérrez-Chico; Julinda Mehilli
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

7.  Oxidative status and cardiovascular risk in women: Keeping pink at heart.

Authors:  Cristina Vassalle; Antonella Mercuri; Silvia Maffei
Journal:  World J Cardiol       Date:  2009-12-31

8.  A new cardiac variable identified?

Authors:  Mark Doyle
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

Review 9.  Women and ischemic heart disease: evolving knowledge.

Authors:  Leslee J Shaw; Raffaelle Bugiardini; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-10-20       Impact factor: 24.094

10.  Impact of gender and dialysis modality on early mortality risk in diabetic ESRD patients: data from a large single center cohort.

Authors:  C Serafinceanu; C Neculaescu; D Cimponeriu; R Timar; A C Covic
Journal:  Int Urol Nephrol       Date:  2013-12-24       Impact factor: 2.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.